Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 374

1.

A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.

Macías D, Oya R, Saniger L, Martín F, Luque F.

Hum Gene Ther. 2009 Nov;20(11):1259-68. doi: 10.1089/hum.2009.059.

PMID:
19604078
[PubMed - indexed for MEDLINE]
2.

StpC-based gene therapy targeting latent reservoirs of HIV-1.

Turner LS, Tsygankov AY, Henderson EE.

Antiviral Res. 2006 Dec;72(3):233-41. Epub 2006 Aug 7.

PMID:
16891001
[PubMed - indexed for MEDLINE]
3.

Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirus.

Popik W, Pitha PM.

Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9573-7.

PMID:
1719535
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Regulation of human immunodeficiency virus-1 latency and its reactivation.

Verdin E.

Bull Mem Acad R Med Belg. 2008;163(6):355-64; discussion 364-5.

PMID:
19445107
[PubMed - indexed for MEDLINE]
5.

Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines.

Zhang RD, Guan M, Park Y, Tawadros R, Yang JY, Gold B, Wu B, Henderson EE.

AIDS Res Hum Retroviruses. 1997 Jan 20;13(2):161-71.

PMID:
9007201
[PubMed - indexed for MEDLINE]
6.

Inducible expression of herpes simplex virus thymidine kinase from a bicistronic HIV1 vector.

Marcello A, Giaretta I.

Res Virol. 1998 Nov-Dec;149(6):419-31.

PMID:
9923018
[PubMed - indexed for MEDLINE]
7.

Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells.

Lassen KG, Ramyar KX, Bailey JR, Zhou Y, Siliciano RF.

PLoS Pathog. 2006 Jul;2(7):e68.

PMID:
16839202
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.

Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, Venuta S.

J Virol. 1993 May;67(5):2853-61.

PMID:
8386279
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Human immunodeficiency virus type 1 (HIV-1) provirus expression and LTR transcription are repressed in NEF-expressing cell lines.

Maitra RK, Ahmad N, Holland SM, Venkatesan S.

Virology. 1991 Jun;182(2):522-33.

PMID:
2024488
[PubMed - indexed for MEDLINE]
10.

Acquisition of HIV-1 resistance in T lymphocytes using an ACA-specific E. coli mRNA interferase.

Chono H, Matsumoto K, Tsuda H, Saito N, Lee K, Kim S, Shibata H, Ageyama N, Terao K, Yasutomi Y, Mineno J, Kim S, Inouye M, Kato I.

Hum Gene Ther. 2011 Jan;22(1):35-43. doi: 10.1089/hum.2010.001. Epub 2010 Dec 12.

PMID:
20649483
[PubMed - indexed for MEDLINE]
11.
12.

Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1.

Williams SA, Kwon H, Chen LF, Greene WC.

J Virol. 2007 Jun;81(11):6043-56. Epub 2007 Mar 21.

PMID:
17376917
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines.

Brack-Werner R, Kleinschmidt A, Ludvigsen A, Mellert W, Neumann M, Herrmann R, Khim MC, Burny A, Müller-Lantzsch N, Stavrou D, et al.

AIDS. 1992 Mar;6(3):273-85.

PMID:
1373627
[PubMed - indexed for MEDLINE]
14.

Selective killing of HIV-1-positive macrophages and T cells by the Rev-dependent lentivirus carrying anthrolysin O from Bacillus anthracis.

Young J, Tang Z, Yu Q, Yu D, Wu Y.

Retrovirology. 2008 Apr 25;5:36. doi: 10.1186/1742-4690-5-36.

PMID:
18439272
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: a new approach to gene therapy of HIV-infection.

Arya SK, Gallo RC.

Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4486-91.

PMID:
8633095
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Antitat gene therapy: a candidate for late-stage AIDS patients.

Lisziewicz J, Sun D, Lisziewicz A, Gallo RC.

Gene Ther. 1995 May;2(3):218-22.

PMID:
7614253
[PubMed - indexed for MEDLINE]
17.

Soluble HIV-1 gp120 enhances HIV-1 replication in non-dividing CD4+ T cells, mediated via cell signaling and Tat cofactor overexpression.

Missé D, Gajardo J, Oblet C, Religa A, Riquet N, Mathieu D, Yssel H, Veas F.

AIDS. 2005 Jun 10;19(9):897-905.

PMID:
15905670
[PubMed - indexed for MEDLINE]
18.
19.

Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.

Lisziewicz J, Sun D, Smythe J, Lusso P, Lori F, Louie A, Markham P, Rossi J, Reitz M, Gallo RC.

Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8000-4.

PMID:
8367455
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Inducible expression of the deltaNGFr/F12Nef fusion protein as a new tool for anti-human immunodeficiency virus type 1 gene therapy.

Muratori C, Schiavoni I, Melucci-Vigo G, Olivetta E, Santarcangelo AC, Pugliese K, Verani P, Federico M.

Hum Gene Ther. 2002 Sep 20;13(14):1751-66.

PMID:
12396627
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk